Medibios Laboratories IPO – Review, Allotment Status, Subscription, Price, Date & more

The Medibios Laboratories Limited is launching its IPO soon. Medibios Laboratories Limited a pharma company based in Mumbai is all set to float an IPO. Let’s have a detailed review of Medibios Laboratories IPO and an in-depth analysis of the IPO release date, IPO offer price, Medibios Laboratories IPO subscription, IPO allotment, grey market price and other details like the company’s background, its financial positions, its promoters and other related things.

Open Demat Account - Offers


Medibios Laboratories IPO Review & Ratings

Medibios Laboratories IPO Ratings & Review
CriteriaRatings
Industry Sentiments 6.1/10
Industry Ranking 6.3/10
Company Background6.5/10
Company Reputation6.2/10
Competitive Edge6.3/10
Financial Statements6.4/10
Popularity Index6.5/10
Promoters Reputation6.5/10
Retail Appetite 6.7/10
Top Brokers Review6.0/10
Overall Ratings 6.4/10
Star Ratings★★★☆☆

Summary of Medibios Laboratories IPO

Medibios Laboratories IPOThe Medibios lab which is powered by great minds is a firm that has widespread recognition. There are clients all over the world. Since the pharma industry is doing too good, if you buy the IPO from this firm, it is sure to do well.

Africa, South East Asia, Latin and CIS nations have accredited the quality of the products from Medibios Laboratories Limited. The products are manufactured by a specialized and dedicated Research and Development team. The company’s location is in India’s global market place, Mumbai. This makes it easy to get recognition for its products. This is yet another reason why one should invest in this IPO. Up to 22, 90,800 Equity Shares of Rs. 10/- each for cash at a price of Rs. [·]/- per share aggregating to Rs. [·] Lakhs.

The promoters of this company are

  • Tushar Korday
  • Rajendra Gole
  • Shailaja Korday
  • Jyoti Gole

The lead manager to the issue is Asit C. Mehta Investment Interrmediates Ltd and the registrar to the issue is Bigshare Services Private Limited.


Subscribe to Medibios Laboratories IPO

    Fill the Details Below
    1. Subscribe to IPOOpen Demat Account

    Medibios Laboratories IPO Date

    The opening and the closing date of the Medibios Laboratories IPO is not known yet.

    Medibios Laboratories IPO Subscription

     Subscription
    Day 1X
    Day 2 X
    Day 3X
    Day 4 X
    Day 5 X

    The IPO issue date has not been announced yet. Once the IPO date has been issued, the subscription details will be updated regularly.

    Medibios Laboratories IPO Allotment Status

    Since the issue date has not been fixed yet, the Allotment Status is not out. The Allotment status will be announced about 3-4 weeks of the IPO issue date.

    Medibios Laboratories IPO Price Band

    The face value of the Equity Shares of our Company is Rs 10/- each and the Issue Price is Rs X the share price.

    Medibios Laboratories IPO Issue Size

    The exact price of the issue size is not known, though the number of equity shares to be issued is known.

    Medibios Laboratories IPO Equity Share Offerings

    Up to 22,90,800 Equity Shares of Rs. 10/- each for cash at a price of Rs. [·]/- per share aggregating to Rs. [·] Lakhs.



    Medibios Laboratories Limited – Company Overview

    Located in the bustling city of Mumbai, this pharma company has got regular clients both inside and outside India. The main aim of the company is to manufacture internationally acceptable products.

    These are some of the range of products that are manufactured by the company and they are in standard with the WHO. The company has customers all over the world.

    • Neutraceuticals
    • Central Nervous System
    • Respiratory System
    • Genito – urinary System
    • Cardivasculars
    • Antiretrovirals
    • Antifungals
    • Antibacterials

    Apart from the R&D team, the products that are manufactured are put through a serious quality assurance check before they are packed. The health of the people is the main concern of this firm.

    The key management personnel of the company

    Sangeeta Dhanuka, Company Secretary & Compliance Officer and the MD of the firm.


    Medibios Laboratories – Financial Statements

    A quick look into the past financial performance of the company to understand its performance of business and evaluate the growth prospectus:

    Assets of the Company

    Assets (in INR & Lakhs)

     31-Mar-1731-Mar-1631-Mar-1531-Mar-1431-Mar-13
    Non-Current Asset1977.931830.311726.311590.31571.78
    Current Assets2116.671456.221805.131417.81331.2
    Total Assets4248.143441.913693.43089.292986.35

    Revenue & PAT of the Company

       Revenue and Profit (in lakhs)

     31-Mar-1731-Mar-1631-Mar-1531-Mar-1431-Mar-13
    Revenue 4960,044008.593723.173621.753307.96
    Profit After Tax 564.89320.55243.02133.9594.35

    Earnings per Equity Share (in Lakh)

     31-Mar-1731-Mar-1631-Mar-1531-Mar-1431-Mar-13
    Basic 7.954.513.421.891.33
    Diluted 7.954.513.421.891.33

    From the above statements, one could find that the garment company has performed well in the past few years.


    Medibios Laboratories IPO – Promoters

    The promoters of this company are

    • Tushar Korday
    • Rajendra Gole
    • Shailaja Korday
    • Jyoti Gole

    Interest of Promoters in the Promotion of the company

    The promoters of the company have promoted the company and they are eligible to obtain the dividends from the company. The promoters of the company also hold some of the key positions in decision making.

    Interest of Promoter in the Property of the company

    The promoters of the company have not shown any interest in acquiring the property of the company. No property has been acquired by them two years since the red draft herring prospectus was filed.

    Interest of Promoter in the Intellectual Rights of the company

    The promoters of the company do not have any interest in any other properties of the company.


    Medibios Laboratories IPO Offer Details or Issue Details

     Particulars No. Of Equity Shares
     Equity Shares OfferedUp to 22,90,800 Equity Shares of Rs. 10/- each for cash at a price of Rs. [·]/- per share aggregating to Rs. [·] Lakhs.
     Of which:
     Reserved for Market Makers Up to 1,15,200 Equity Shares of Rs. 10/- each for cash at a price of Rs. [·]/- per share aggregating Rs. [·] Lakhs.
     Net Issue to the Public
     Of which:
     Retail Investors Portion The number of Equity Shares in multiples of [●] Equity Shares at an Issue price of Rs. [●] each, such that the Application Value does not exceed Rs. 2.00 Lakh
     Non-Retail Investors PortionA number of Equity Shares in multiples of [●] Equity Shares at an Issue price of Rs. [●] each, such that the Application Value exceeds Rs. 2.00 Lakh.
     Equity Shares outstanding prior to the Issue71,04,600 Equity Shares of the face value of Rs. 10/- each
     Equity Shares outstanding after the IssueUp to 86,59,800 Equity Shares of the face value of Rs. 10/- each

     


    Medibios Laboratories IPO Issue Object

    These are the IPO Issue Objects of the company

    • To modernize and expand the existing the general division of the company and to set up a veterinary division
    • To market the products and register the formulations
    • The IPO money would also be used for general corporate purposes

    List of Upcoming IPOs in 2018

    G R InfraProjects IPOBright Solar IPOShree Vasu Logistics IPOFinecure Pharmaceuticals IPO
    Yash Highvoltage IPOLatteys Industries IPOSonam Clock IPOShiva Industrial IPO

    Medibios Laboratories IPO – Basis of the Offer Price

    The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors. The face value of the Equity Shares of our Company is ` 10/- each and the Issue Price is Rs [●] the share price.

    Qualitative factors are:

    • Technical know-how
    • Geographical location
    • Recurring business from existing customers
    • Competitive cost
    • Strong regulatory team
    • Focus on quality control
    • Experienced management team
    • Diversified product

    The relevant quantitative factors are:

    • Basic & Diluted Earnings per share (EPS) (Face value of ₹ 10 each), as adjusted for change in capital
    • Price Earning (P/E) Ratio in relation to Price of ₹ [●] per Equity Share
    • Average Return on Net worth (RoNW)
    • Minimum Return on Net Worth after Issue to maintain Pre-Issue EPS
    • Net Asset Value (NAV) per Equity Share (Face Value Rs 10 each)
    • Comparison of Accounting Ratios with Industry Peers

    List of Latest IPOs of 2018

    SoftTech Engineers IPOAkshar Spintex IPOGodha Cabcon Insulation IPOIndo US Biotech IPO
    E2E Networks IPODr. Lalchandani Labs IPOKims Hospitals IPOMegastar Foods IPO

    Medibios Laboratories IPO Lead Managers

    Lead Managers
    Asit C. Mehta Investment Intermediates Ltd

    Medibios Laboratories IPO Registrar to offer

    Registrar to the Issue
    Bigshare Services Private Limited

    Medibios Laboratories IPO Review by Top 10 Stock Brokers

    Top Stock Brokers ReviewCompany ReputationCompetitive EdgeFinancial StatementPopularity IndexPromters Reputation
    Angel Broking6.4/106.6/106.0/106.4/106.0/10
    Sharekhan6.2/106.1/106.6/106.1/106.2/10
    Kotak Securities6.3/106.2/106.3/106.4/106.3/10
    ICICI Direct6.3/106.3/106.7/106.1/106.1/10
    IIFL6.2/106.2/106.8/106.0/106.1/10
    Edelweiss6.2/106.3/106.3/106.3/106.2/10
    Zerodha6.3/106.4/106.3/106.3/106.0/10
    5Paisa6.1/106.4/106.3/106.1/106.1/10
    Karvy6.3/106.3/106.2/106.1/106.0/10
    Motilal Oswal6.3/106.4/106.3/106.5/106.4/10

    The ratings would be updated once the financials and the other details of the IPO are released.


    Medibios Laboratories IPO Grey Market Premium

    The  Medibios Laboratories Limited IPO Grey Market Premium is yet to be announced. It will be updated as soon as the premium rates are announced.r


    Calculate your return on investment!



    Asset ClassROI (Rs.)Profit (Rs.)Profit (%)
    IPO
    Equity
    Savings
    Real Estate
    Gold
    Bonds
    Fixed Deposit
    Mutual Fund


    Subscribe to Medibios Laboratories IPO

      Fill the Details Below
      1. Subscribe to IPOOpen Demat Account

      Medibios Laboratories IPO News

      News 1 – IPO ISSUES OPEN SOON


      Market Guide

      What is IPO?IPO InvestmentIPO ValuationUpcoming IPOsIPO Review

      Featured Topics

      5Paisa vs Upstox
      5Paisa vs Karvy
      5Paisa vs Axis Direct
      5Paisa vs SBI Cap Securities
      5Paisa vs Anand Rathi
      5Paisa vs Religare Securities
      5Paisa vs Reliance Securities
      5Paisa vs Ventura Securities
      5Paisa vs SAMCO
      5Paisa vs Bonanza Portfolio
      5Paisa vs HDFC Securities
      5Paisa vs IIFL
      5Paisa vs Edelweiss
      5Paisa vs Motilal Oswal
      5Paisa vs ICICI Direct
      5Paisa vs Kotak Securities
      5Paisa vs Angel Broking
      5Paisa vs Sharekhan
      5Paisa vs Zerodha

       

      Get 100% IPO Allotment Guarantee! Subscribe to IPO
      ×

      Share your details & Become Sub Broker Now!

        1. Become Sub Broker

        Offer valid for limited time.

        ×

        Share your details & Open Demat A/C Now!

          1. Open Demat Account

          Offer valid for limited time.

          ×

          Share your details & Get IPO Allotment Now!

            1. Invest in IPO

            Offer valid for limited time.

            ×

            Share your details & Invest in PMS Now!

              1. Invest in PMS / PCG

              Offer valid for limited time.